InfographicsClinical benefits of icosapent ethyl in cardiovascular disease: findings from REDUCE-IT trials
Check out and download our latest infographics highlighting the important findings of the REDUCE-IT Trials. The multicenter, placebo-controlled, double-blind trial REDUCE-IT assesses the therapeutic effects of icosapent ethyl, a stable eicosapentaenoic acid ethyl ester, in such patients.
First published: December 13, 2021
Check out and download our latest infographics highlighting the important findings of the REDUCE-IT Trials. The multicenter, placebo-controlled, double-blind trial REDUCE-IT assesses the therapeutic effects of icosapent ethyl, a stable eicosapentaenoic acid ethyl ester, in such patients.
First published: December 13, 2021